-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Integrated Biopharma Inc annual/quarterly Deferred Income Tax Expense (Benefit) history and growth rate from Q3 2018 to Q3 2024.
- Integrated Biopharma Inc Deferred Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $197K, a 2363% increase year-over-year.
- Integrated Biopharma Inc annual Deferred Income Tax Expense (Benefit) for 2025 was $1.26M, a 911% increase from 2024.
- Integrated Biopharma Inc annual Deferred Income Tax Expense (Benefit) for 2024 was $125K, a 73.6% increase from 2023.
- Integrated Biopharma Inc annual Deferred Income Tax Expense (Benefit) for 2023 was $72K.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)